Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | N-(3-aminophenyl)sulfonylacetamide | HCID 504048 | — |
| Reactant | HCID 21480451 | HCID 21480451 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 131718766 | HCID 131718766 | 65.2% |
Reaction Steps
The title compound was prepared in the same way as that described in Example 11, Step 4, using 5-cyclohexyl-l,3-dihydro-1-methyl-3(R,S)-[(4-nitrophenyloxycarbonyl)amino ]-2H-1,4-benzodiazepin-2-one (0.5 g, 1.2 mmol), triethylamine (0.16 ml, 1.2 mmol), dimethylformamide (10 ml) and 1-(methylcarbonylaminosulphonyl)-3-aminobenzene (0.26 g, 1.2 mmol).After recrystallisation from methanol, the title compound (0.2 g, 34%) was afforded as a colourless solid. mp 195°-198° C. 1H NMR (360 MHz, D6 -DMSO) δ 0.87-0.99 (1H, m), 1.10-1.66 (7H, m), 1.78 (1H, m), 1.94 (1H, m), 1.91 (3H, s), 2.95 (1H, m), 3.30 (3H, s), 5.07 (1H, d, J=8.3 Hz), 7.39 (4H, m), 7.54 (2H, m), 7.64 (1H, dd, J=7.9 and 7.9 Hz), 7.76 (1H, d, J=7.9 Hz), 8.07 (1H, s), 9.42 (1H, s), 11.99 (1H, brs).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05360802 |
|---|
| Source dataset | uspto-grants-1994_11 |
|---|
| ORD ID | ord-08acf4f698aa480ea785d9605a6f2bb4 |
|---|
| Source note | uspto-grants-1994_11 |
|---|